“Today, all those living with type 1 diabetes, and an estimated 63 million living with type 2 diabetes, use insulin. Despite the fact that insulin has been used for nearly 100 years, an estimated 1 in 2 people who need it cannot afford and/or access this much-needed medicine. Various factors can affect access to insulin, including issues at both national and global levels. Building on previous studies focused at country-level, Health Action International’s (HAI) Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study has been working to identify and address the inequities and inefficiencies in the global insulin market. Marg Ewen and Molly Lepeska will present the main research findings of this multi-year study, including issues related to global market structure, intellectual property, trade, prices, taxes and tariffs. They will share their main conclusions and offer recommendations to increase the affordability and availability of this essential medicine around the world.”
Speakers
Marg Ewen, Senior Projects Manager (Medicines Prices), Health Action International
Molly Lepeska, Project Manager (ACCISS Study), Health Action International
……………
Source, registration: Global Health Centre, The Graduate Institute